We describe two patients who developed subacute axonal peripheral neuropathy under duodopa treatment. Comprehensive diagnostic workup including muscle and sural nerve biopsy revealed that the most probable cause of subacute axonal peripheral neuropathy was cobalamin and vitamin B6 deficiency in both the patients.

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.23342DOI Listing

Publication Analysis

Top Keywords

subacute axonal
12
cobalamin vitamin
8
vitamin deficiency
8
axonal peripheral
8
peripheral neuropathy
8
axonal neuropathy
4
neuropathy parkinson's
4
parkinson's disease
4
disease cobalamin
4
deficiency duodopa
4

Similar Publications

Systemic administrations of protamine heal subacute spinal cord injury in mice.

Neurosci Res

December 2024

Department of Biochemistry, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan; Institute for Glyco-core Research (iGCORE), Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan. Electronic address:

Spinal cord injury (SCI) results in damage to neural circuits that cause long-term locomotor and sensory disability. The objective of the present study is to evaluate whether a clinical drug, protamine, can be employed as a therapeutic agent for SCI. First, we examined the rescue effect of protamine on dystrophic endballs (DEs) cultured on a chondroitin sulfate (CS) gradient coating.

View Article and Find Full Text PDF
Article Synopsis
  • Nitrous oxide, commonly used as an anesthetic, is increasingly abused recreationally, leading to neurological issues in users.
  • A study reviewed seven patients aged 19-32 who inhaled nitrous oxide and subsequently experienced ataxia and sensory dysfunction, with some showing coexisting encephalopathy.
  • Although patients had poor short-term outcomes, most showed significant recovery after more than six months, indicating potential long-term improvement despite initial symptoms.
View Article and Find Full Text PDF

A man in his 30s with a history of refractory classical Hodgkin's lymphoma presented with subacute onset asymmetric sensory disturbance, and severe weakness affecting his right more than left hand. Symptom onset was 18 weeks after commencing brentuximab vedotin (BV) treatment, an anti-CD30 antibody drug-conjugate for relapsed/refractory classical Hodgkin's lymphoma. Symptoms progressed to his lower limbs with distal sensory loss, gait imbalance, bilateral foot drop and mild proximal leg weakness.

View Article and Find Full Text PDF

Aims: Limited understanding of neurobiological mechanisms of repetitive transcranial magnetic stimulation (rTMS) prevents us from choosing optimal therapeutic regimen for patients to improve therapeutic efficiency. Resting-state functional magnetic resonance imaging (rs-fMRI) has been demonstrated to obtain comparable functional readouts across species.

Methods: Intermittent and continuous theta burst stimulation were used to stimulate ipsilesional and contralesional hemisphere, respectively, during the subacute phase after stroke.

View Article and Find Full Text PDF

Challenges in advancing Schwann cell transplantation for spinal cord injury repair.

Cytotherapy

January 2025

The Miami Project to Cure Paralysis and Neurological Surgery, Miller School of Medicine, University of Miami, Miami, FL, USA.

Background Aims: In this article we aimed to provide an expert synthesis of the current status of Schwann cell (SC)therapeutics and potential steps to increase their clinical utility.

Methods: We provide an expert synthesis based on preclinical, clinical and manufacturing experience.

Results: Schwann cells (SCs) are essential for peripheral nerve regeneration and are of interest in supporting axonal repair after spinal cord injury (SCI).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!